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1. Introduction 
Staphylococcus is a genus of worldwide distributed bacteria correlated to several infectious of 
different sites in human and animals. Its importance is not only because of its distribution 
and pathogenicity but especially due to its ability to overcome antimicrobial effects. The 
goal of this chapter is to report data obtained from a decade of research in animal science 
field concerning to staphylococci antimicrobial resistance.  
2. Characteristics and distribution of Staphylococci species in animals:  
An overview 
The genus Staphylococcus is in the bacterial family Staphylococcaceae (Ludwig, 2009). 
Staphylococci are Gram-positive spherical bacteria that occur in clusters resembling grapes 
due to its perpendicular division planes where cells remains attached to one another 
following each successive division.  
The genotypic standards for assigning an organism to the genus Staphylococcus include 
determination of guanine plus cytosine (G+C) content of 30-39mol% and phylogenetic trees 
constructed by comparison of 16S rRNA or 23R rRNA sequences (Takahashi et al., 1999). 
The phenotypic criteria is based on the ultrastructure and chemical composition of the cell 
wall, typical form Gram positive bacteria and catalase reaction positive for all species, 
except for S. aureus subsp anaerobius and S. saccharolyticus, which are strictly anaerobic. This 
genus comprises more than 50 species separated into two distinct groups based on their 
ability to produce coagulase. This topic approaches Staphylococcus spp distribution 
considering that different animal species have specific staphylococcal microbiota. Otherwise 
some clonal strains can colonize different animal species as is the case of methicillin-
resistant Staphylococcus aureus (MRSA). Molecular techniques have been used to relate clonal 
groups of MRSA isolated from different animal species in order to understand its model of 
dissemination. 
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2.1 Coagulase-positive Staphylococci 
This group includes the major pathogenic Staphylococcus species. Staphylococcus aureus is 
considered the most pathogenic one, especially due to its ability to produce a large range of 
virulence factors that enables it to colonize different tissues of a large range of animal 
species. The coagulase protein has the ability to turn fibrinogen into fibrin threads by a 
mechanism different from natural clotting (Palma et al., 1999). This protein is codified by the 
gene coa which possess a conserved and a repeated polymorphic region that can be used to 
measure relatedness among Staphylococcus coagulase positive isolates (Reinoso et al., 2006). 
The variable region of coa is comprised of 81-bp tandem short sequence repeats (SSRs) that 
are variable in both number and sequence, as determined by restriction fragment length 
polymorphism analysis of PCR products (Goh et al., 1992). 
Staphylococcal protein A is a membrane-bound exoprotein characterized and well known 
for its ability to bind to the Fc region of immunoglobulins of most mammalian species. This 
protein is encoded by the spaA gene with a polymorphic (X) and a conserved region. The 
polymorphic X region consists of a variable number of repeated 24 pairs of bases located in 
the coding region for the cellular wall C-terminal extremity (Koreen et al., 2004). The 
diversity of the spaA short sequence repeat region seems to arise from deletion and 
duplication of the repetitive units and also by point mutation and this variation can be used 
in epidemiological studies. Frenay et al. (1994) reported epidemic MRSA strains with more 
than seven repeats and Montesinos et al. (2002) described isolates with 11 repeats as the 
most common type involved in an epidemic human outbreak caused by MRSA. The coa 
typing can be used to enhance the value of spa typing by providing more supported 
inferences on strain lineage and clonality among isolates with similar or identical spa repeat 
organization (Tenover et al., 1994). The use of more than one genetic marker for relating 
strains is desirable and likely to become increasingly important because recombination will 
eventually diversify resistant staphylococcal species to the extent that clonal types within a 
given region can no longer be distinguished by a single locus. 
Staphylococcus aureus also produces others exoproteins that contribute to its ability to 
colonize host tissues such as slime and hemolysins. The adherence and fixation of S. aureus 
on biological surfaces represent the fundamental step in the development of infections. The 
production of slime mediates adhesion to implanted surfaces acting as a cementing matrix 
making bacteria less accessible to the host’s defense system (Coelho et al, 2009). Slime 
production is controlled by the ica operon (icaADBC) and the co-expression of the icaA and 
icaD genes leads to a significant increase in such production (Arciola et al., 2001). 
The alpha and beta hemolysins are important factors in the pathogenesis of Staphylococcal 
infections. The beta-toxin is an Mg2+-dependent sphingomyelinase C which degrades 
sphingomyelin in the outer phospholipid layer of the membrane (Linehan et al., 2003).  
The agr (accessory gene regulator) operon (agrA, agrB, agrC agrD and hld) is recognized as a 
quorum-sensing gene cluster that up-regulates production of secreted virulence factors such 
as alpha and beta-hemolysins, proteases, DNAses and sphingomyelinase. This same cluster 
also down-regulates the production of cell-associated virulence factors in a cell density-
dependent manner in S. aureus (Lyon et al., 2000). The agr locus comprises two divergent 
transcriptional units under the control of the promoters P2 (RNA II) and P3 (RNA III). The 
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P3 transcript, an RNA III molecule, mediates the up-regulation of secreted virulence factors 
as well as the down-regulation of surface proteins (Novick, 2000).  
Coelho et al. (2011) evaluated the presence of some Staphylococcus aureus virulence genes, 
including coa, spaA, hla e hlb in order to understand the distribution of S. aureus strains in 
dairy farms at Rio de Janeiro, Brazil, and contribute to the establishment of preventive 
strategies to reduce the spread of infection. 
In veterinary medicine, others coagulase-positive staphylococci are reported as important 
pathogens, such as Staphylococcus intermedius, whose reclassification was proposed by 
Devriese et al. (2005), creating the S. intermedius group (SIG) including S. intermedius, a new 
specie S. pseudintermedius and S. delphini. Like S. aureus, the S. intermedius strains isolated 
from animals have been reported to produce an array of virulence factors, including 
leukotoxin, enterotoxin, and hemolysins, together with elements essential for biofilm 
formation (Futagawa-Saito et al., 2006). Besides SIG, others significative coagulase-positive 
in animals are S. schleiferi subsp. coagulans, S. aureus subsp. anaerobius.  
2.2 Coagulase-negative Staphylococci 
This group comprises the majority of Staphylococcus species. Coagulase-negative 
staphylococci (CNS), which were traditionally considered to be minor infectious pathogens, 
have become more common (Huxley et al., 2002). Several CNSs have been isolated from 
animal clinical specimens such as Staphylococcus epidermidis, Staphylococcus simulans, 
Staphylococcus xylosus, Staphylococcus chromogenes, Staphylococcus warneri, Staphylococcus 
haemolyticus, Staphylococcus sciuri, Staphylococcus saprophyticus, Staphylococcus hominis, 
Staphylococcus caprae, Staphylococcus cohnii subsp. cohnii, Staphylococcus cohnii subsp. 
urealyticus, Staphylococcus capitis subsp. capitis and Staphylococcus capitis subsp. urealyticus 
(Lilenbaum et al., 2000; Pereira et al., 2009; Pyöräla et al., 2009; Soares et al., 2008).  
The conventional methods for CNS identification were primarily developed for human 
strains and their poor performance for identifying strains of animal origin seems to be 
related to a limited number of veterinary strains in databases (Bes et al., 2000). Additionally, 
the reference method developed by Bannerman (2003) is costly and too time consuming to 
be used in a clinical laboratory. Several molecular targets have been exploited for the 
molecular identification of Staphylococcus species, including the groEL gene (Goh et al., 1996). 
This gene, which encodes a 60-kDa polypeptide (known as GroEL, 60-kDa chaperonin, or 
HSP60 for heat shock protein 60) has the potential to serve as a general phylogenic marker 
because of its ubiquity and conservation in nature (Segal & Ron, 1996). Also it was proven to 
be an ideal universal DNA target for identification to the species level because it has well-
conserved DNA sequences within a given species, but with sufficient sequence variations to 
allow for species-specific identification (Goh et al., 1996). Santos et al., (2008) had 
successfully used the groEL gene as a tool for the identification of the main Staphylococcus 
coagulase-negative species by PCR restriction fragment length polymorphism (RFLP). This 
group investigated 54 cows from 23 dairy herds located in the Brazilian States of Minas 
Gerais, Rio de Janeiro and São Paulo, between 1995 and 2003 and concluded that this gene 
constitutes a reliable and reproducible molecular method for identification of CNS species 
responsible for bovine mastitis.  
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2.3 Staphylococcal infections in animals 
Reports of the importance of Staphylococcus species as pathogens in animal infections have 
been described and appear to be increasing. Among coagulase-positive species, 
Staphylococcus aureus is a cause of mastitis, dermatitis and suppurative conditions in several 
animal species. S. aureus causing mastitis is widely distributed in cattle, goats and sheep. 
The infection is often subclinical in cattle, leading to reduced milk production and milk 
quality, but acute catarrhal or even gangrenous inflammation may also occur.  
For a long time, S. intermedius had been majorly considered a primary cause of pyoderma in 
dogs. It has also been reported to be involved in other diseases, such as pyometra, otitis 
externa and purulent infections of the joints, eyelids and conjunctiva (Werckenthin et al., 
2001). Nowadays, a new classification was proposed by Devriese et al. (2005), creating the S. 
intermedius group (SIG) including S. intermedius, a new specie S. pseudintermedius and S. 
delphini. According to Sasaki et al. (2007), S. pseudintermedius is actually the major specie 
involved in this pathology. Futhermore, according to these authors, S. intermedius is 
restricted to feral pigeons and S. delphini which was usually described as the cause of 
suppurative skin lesions in dolphins is now considered to be involved in a larger spectrum 
of infectious animal diseases. S. aureus subsp. anaerobius has been implicated in 
lymphadenitis in sheep and S. schleiferi subsp. coagulans in external otitis in dogs.  
Coagulase Negative Staphylococci (CNSs) have also been studied considering its potential 
pathogenicity for human and animals. Nowadays these bacteria are of great interest in 
veterinary medicine because they are currently considered emerging pathogens of bovine 
mastitis. Although CNS are not as pathogenic as the other principal mastitis pathogens and 
infection mostly remains subclinical, they can cause persistent infections, which result in 
increased milk somatic cell count (SCC) and decreased milk quality (Pyorala & Taponen, 
2009). The prevalence of CNS mastitis is higher in primiparous cows than in older cows. 
Also this agent is implicated in the etiology of infectious diseases in household pets (Pereira 
et al., 2009). The most frequently isolated CNS species vary according to the geographical 
region under scrutiny and sample origin. In Brazil, Soares et al. (2008) detected prevalence 
of S.xylosus in mastitic milk samples, despite S. chromogenes, S. simulans and S. epidermidis, in 
general, appear to be the most frequently isolated CNS from mammary secretion samples 
worldwide (De Vliegher et al., 2003; Taponen et al., 2006).  
Besides, S. hyicus, a variable coagulase producer, but mainly coagulase-negative, causes 
exudative epidermitis (“greasy pig disease”) and an often acute generalized skin infection in 
piglets. Systemic forms of the disease which result in the death of the animals are also seen. 
Poor hygienic conditions as well as ec 
toparasitic infestations favour the onset of the S. hyicus infection. Surviving piglets show 
retarded growth rates. In adult pigs, subacute skin infections, mastitis or metritis, but also 
septic arthritis may be caused by S. hyicus (Brückler et al., 1994). In goats and sheep 
however, enzootic acute gangrenous mastitis is commonly seen. 
3. Antimicrobial resistance in Staphylococci of animal origin 
Antibiotic resistance is the most puzzling question of public healthy in the earlier decade of 
this 21st century. Among bacteria this question seems to be more alarming due to its short 
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generation time and efficient gene recombination mechanisms. Staphylococcus aureus is the 
most representative example of how antibiotic resistance is a serious threatening 
worldwide. Nevertheless, all others coagulase-positive staphylococci are also able to 
develop resistance mechanisms to a large range of antimicrobials. Furthermore, the strains 
of several CNS species were also found to have high levels of resistance to various 
antibiotics.  
This topic will discuss features of the resistance of staphylococci to antimicrobials, specially 
methicillin (oxacillin) and vancomicin, its mechanisms and epidemiology. Crucial questions 
about the use or abolishment of antibiotics used as “growth promoters” to food animal 
production will also be discussed. 
3.1 Methicillin resistance 
ß-lactamic antibiotics are the most frequently used in anti-staphylococcal infection therapy. 
Bacterial resistance mechanisms to this class of antibiotics include production of ß-
lactamases and low-affinity penicillin-binding protein 2a (PBP2a) determined by the 
presence of the chromosomal genes bla and mecA, respectively. The latter, designated for 
methicillin resistance, precludes therapy with any of the currently available ß-lactam 
antibiotics, and may predict resistance to several classes of antibiotics (Moon et al., 2007). 
The isolation of Staphylococcus aureus methicillin- resistant (MRSA) from animals was first 
reported in 1972 following its detection in milk from mastitic cows (Devriese et al., 1972). 
Recent works reports a low incidence of MRSA mastitis and low prevalence of methicillin 
resistance among bovine S. aureus isolates (Juhász-Kaszanyitzky et al., 2007; Lee, 2003; Moon 
et al., 2007) so clinically it can be concluded that MRSA does not appear to be an important 
bovine mastitis pathogen. Nevertheless, the importance of epidemiological data concerns 
about MRSA in animals is reasonable and requires careful study in order to understand its 
emergence and dissemination. The long-term low prevalence of MRSA mastitis is quite 
surprising given the number of years since the first identification of MRSA in cattle and the 
close contact of humans with the udders of dairy cattle. Otherwise, several reports have 
been published showing MRSA infection in domestic animals, including dogs, cats, cattle, 
sheep, chickens, rabbits, and horses as an increasing trend (Goni et al., 2004; Hartmann et al., 
1997; Lee, 2003; O’Mahony et al. 2005;  Rich & Roberts 2004; Weese, 2005; Weese et al., 2006).  
It is certain that animals are a source of human MRSA infection in some circumstances, but 
humans may also serve as sources of infection in animals. Exposure of household pets to 
MRSA was probably inevitable due to its increasingly prevalence in humans. Changes in the 
epidemiology of MRSA in unique specie may be reflected in changes in other species. The true 
scope of MRSA in animals and its impact on human health are still only superficially 
understood, but it is clear that MRSA is a potentially important veterinary and public health 
concern that requires a great deal more study to enhance understanding and effective response 
(Weese & Van Duijkeren, 2010). While most animals with MRSA are merely colonized, a wide 
range of clinical infections can occur. As would be expected with staphylococci, most MRSA 
infections in pets affect the skin and soft tissue. Wound infections, surgical site infections, 
pyoderma, otitis, and urinary tract infections are most common, but various other 
opportunistic infections have been reported (Baptiste et al., 2005; Griffeth & Morris, 2008). In a 
research developed by our team, 8% of MRSA was detected in a hundred of clinical specimens 
from different sites of household pets evaluated (Pereira et al., 2009).  
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Recently, a new MRSA was identified using high throughput DNA microarray screening. 
Complete genome sequencing revealed that this strain is distinctly different to previously 
described MRSA. It carries a new type of SCCmec encoding highly divergent genes that are 
very different to any described previously in MRSA or in any other organism. It was found 
to belong to the genetic lineage clonal complex 130 (CC130), which has previously only been 
associated with MSSA from cows and other animals, but not humans, strongly suggesting 
that the new MRSA originated in animals. (Gárcia-Alvarez et al., 2011) 
Staphylococcal cassette chromosome mec (SCCmec) is a mobile genetic element composed by 
mec and ccr genes complex, which encodes methicillin resistance and the recombinases 
responsible for its mobility, respectively (Katayama et al., 2000). The expression of PBP-2a is 
controlled by regulator elements encoded by mecR1 and mecI which are located adjacent to 
mecA on the chromosome. Deletion or mutation which occurred in mec regulator gene is 
considered to be associated with constitutive production of PBP-2a. Hence Staphylococcus 
spp possessing intact mecRI and mecI as well as mecA are phenotypically methicillin 
susceptible because of the repression of PBP-2a production by mec regulator elements. Such 
genomic changes in mec regulator genes are considered to alter or remove their repressor 
function on mecA gene transcription, which may lead to constitutive production of PBP-2a. 
The mec gene complex has been classified into four classes, and the ccr gene complex has 
been classified into three allotypes. Different combinations of mec and ccr gene complex 
types have so far defined six types of SCCmec elements (type I, II, III, IV, V) (Ito et al., 2004). 
It is important to analyze the genomic diversity found in mec regulator genes of 
staphylococci in order to understand the molecular basis for methicillin resistance. 
The detection of methicillin resistance in routine clinical laboratories has been problematic 
ever since the emergence of MRSA during the 1960s and the difficulties are associated 
mainly with heterogeneous expression of resistance in most staphylococal strains currently 
prevalent (Witte et al., 2007). Misidentification of methicillin resistance can have serious 
adverse clinical consequences. False-susceptibility may result in treatment failure and in the 
spread of resistant Staphylococcus spp making it difficult to apply control measures and 
leading to the increasing of healthcare costs and may lead to overuse of glycopeptides 
(Velasco et al., 2005).  
3.2 Vancomicin resistance 
The glycopeptide vancomycin was first released in 1958. Vancomycin is an inhibitor of cell 
wall synthesis in S. aureus and other gram-positive organisms. While beta-lactam antibiotics 
inhibit cell wall synthesis by binding to the transpeptidase active site of penicillin binding 
proteins, vancomycin acts by a completely different mechanism so it has been the treatment 
of choice for serious infections caused by MRSA (Howden et al., 2010), but increase in 
vancomycin use has led to the emergence of two types of glycopeptide-resistant S. aureus. 
The first one, designated vancomycin intermediate resistant S. aureus (VISA) and the 
vancomycin-resistant S. aureus (VRSA).  
The first report of clinical S.aureus isolate with reduced vancomycin susceptibility (VISA) 
was made by Hiramatsu et al. (1997) and generated great concern in the medical 
community. From there on, reports of strains of S. aureus (predominately MRSA) 
demonstrating the heterogeneous VISA (hVISA) or VISA phenotype have now been 
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reported for many countries including the United States, Japan, Australia, France, Scotland, 
Brazil, South Korea, Hong Kong, South Africa, Thailand, Israel, and others (Bierbaum et al. 
1999; Chang et al., 2003; Denis et al. 2002; Ferraz et al., 2000 Gemmell, 2004; Howden et al., 
2010; Kim et al., 2000; Perichon & Courvalin, 2006; Sng et al.,2005; Song et al., 2004; Tenover 
et al., 2004; Weigel et al., 2007) 
Nowadays it is conceivable that VISA phenotype is related to the bacterial cell wall 
thickening, a passive resistance mechanism that reduces vancomycin access to its active site, 
which is localized in the cytoplasmic membrane in the division septum (Howden et al., 
2010). It results in accumulation of acyl-D-alanyl-D-alanine (X-DAla-D-Ala) targets in the 
periphery that sequester glycopeptides (Cui et al., 2003). 
Since 2002, nine methicillin-resistant Staphylococcus aureus (MRSA) strains that are also 
resistant to vancomycin (VRSA) have been reported in the United States. The fully 
vancomicin-resistant Staphylococcus aureus phenotype (VRSA) is due to acquisition from 
Enterococcus spp. of the vanA operon, carried by transposon Tn1546, resulting in high-level 
resistance (Arthur et al., 1993, Patel et al., 1997). 
The emergence of enterococci vancomicin-resistant strains has been related to the use of 
avoparcin as growth promoter in swine culture (Aarestrup et al., 1996). Studies report the 
transfer of glycopeptide- and macrolide-resistance genes by transconjugation among 
enterococci and from Enterococcus faecalis to S. aureus (Młynarczyk et al., 2002). The 
vancomycin-resistance gene acquisition by S. aureus from E. faecium in the clinical 
environment has also been reported by Weigel et al. (2007). Recently, Tiwari & Sen (2006) 
have reported a VRSA which is van gene-negative. 
In veterinary medicine, vancomycin-resistant enterococci were isolated from the feces of 
poultry and pig herds. It has significant impact in public healthy cause dissemination via 
contaminated animal food products possible (Aarestrup, 1995). These vancomycin-resistant 
E. faecium isolates from animals had decreased susceptibilities to avoparcin, a glycopeptide 
antibiotic widely used as a growth promoter in Western Europe and Australasia. Avoparcin 
is a fermentation product from a strain of Streptomyces candidus and is closely related to 
vancomycin (Aarestrup et al., 1996). Aarestrup et al (1996) showed that E. faecium isolates 
coresistant to vancomycin and avoparcin are commonly found in the feces of pigs and 
poultry in Denmark.  
3.3 Others antimicrobials resistance 
In Veterinary Medicine, clindamycin has been chosen as an antimicrobial alternative for the 
treatment of infections in dogs and cats caused by methicillin-resistant Staphylococcus aureus 
(MRSA) (Walther et al., 2008; Weese et al., 2006) and methicillin-resistant Staphylococcus 
pseudintermedius (MRSP) (Schwarz et al., 2008; Wettstein et al., 2008). However, an inducible 
form of clindamycin-resistance may be present in some staphylococci. These staphylococcal 
strains appear susceptible on routine antimicrobial susceptibility testing, but resistance can 
be induced during treatment, possibly resulting in treatment failure (Swenson et al., 2007; 
Yilmaz et al., 2007). 
Azithromycin have a remarkable application due to its superior pharmacokinetics properties 
and broad spectrum activity, including Gram-positive and negative bacteria species, 
intracellular pathogens and protozoan parasites. The principal characteristic that supported its 
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prescription and clinical significance is that it can be administrated by oral and parental routes, 
only by a single daily dose in short period of treatment facilitating veterinary therapy. 
Nevertheless, most of the knowledge that supports its use in veterinary therapy was based on 
studies that proved its therapeutic efficacy in human infections. Empirical antimicrobial 
chemotherapy without previous accomplishment of bacterial identification and antimicrobial 
susceptibility assays contributes to increase of antimicrobial resistance prevalence in pet 
animal reservoirs (Guardabassi et al., 2004; Morgan et al.; 2008).  
Pereira et al. (2009) evaluated azithromycin resistance among 100 staphylococci isolates from 
pet animals infections. It was detected a percentual of resistant isolates of 54% to Staphylococcus 
intermedius, 67% of S. aureus, 38% of S. hyicus, 67% of coagulase-negative Staphylococcus spp 
through disc diffusion test. The variability of azithromycin susceptibility pattern is different to 
what is observed in humans infections whereas Staphylococcus aureus is the classical isolated 
pathogen. Broth dilution test detected azithromycin MIC50/90 values of 16g/mL, 64g/mL in 
staphylococci isolates, respectivally, and 256g/mL in Gram-negative rods (GNR). Agar 
dilution azithromycin MIC50/90 values corresponded to 32g/mL and 256g/mL in 
staphylococci and 512g/mL in GNR. Crescent azithromycin resistance rate has been 
previously reported. A study from 90’s decade, detected azithromycin MIC50/90 128 g/mL of 
MRSA isolated from human clinical samples (Neu, 1991). When comparing human MIC 
values reported in literature to data obtained from pet animal samples in the present study, 
azithromycin activity pattern may vary from different bacteria species and hosts, leading to 
therapeutic failures when classical human pathogens are adopted as reference to calculate 
dose and drug concentration. This justify microbiologic and pharmacokinetic assays to 
determine the specific azithromycin susceptibility breakpoints and therapeutic drug 
concentration to different bacteria species detected from animal disease.  
It is important to point that MIC50 values varied among different staphylococci species, such 
as, Staphylococcus intermedius (32g/mL), S. hyicus (32g/mL), CNS (32g/mL), from that 
value detected in S. aureus (16g/mL) isolated from pet animal specimens.  
Pereira et al. (2009) also evaluated the genetic markers of Staphylococcus spp azithromycin 
resistance by PCR technique and detected a 39% prevalence of erm genes, being ermC gene 
the most detected, showing a prevalence of 24% among all Staphylococcus isolates, followed 
by 12% ermA and 3% of ermB. No isolates were positive to mefA gene, what may support the 
theory about methylase ribossomal modification as the principal resistance mechanism 
associated to macrolide resistance among staphylococci. The expression of erm genes can be 
inducible or constitutive. When expression is constitutive, the staphylococci are resistant to 
all macrolide, lincosamide and streptogramin B (MLSB) antimicrobials (Schmitz et al., 2000). 
In this study, it was detected MLSB resistance in 14% constitutive azithromycin-resistant 
Staphylococcus spp. Inducible resistance phenotype, expressed by a “D zone” next to 
clindamycin disc was available in 5% (5/100) of Staphylococcus spp. 
Most of the knowledge applied to define microbiologic use and dose of azithromycin was 
based on Staphylococcus aureus assays, because this specie acts as classical pathogen of 
human infections, but the frame of etiology and antimicrobial susceptibility pattern change 
when animal pathogens are considered. 
Gentamicin is one of the most used antibiotics in dairy farm cattle. It is especially used as a 
prophylactic measure of mastitis control through intramammary injection. Its principal 
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resistance mechanism is mediated by the production of enzymes which transform 
aminoglycosides into inactive derivatives, such as acetyltranspherases, adenylyltranspherases 
and phosphotransferases. Modified aminoglycosides lose the ability to bind ribosomes and 
inhibit bacterial protein synthesis (Watanabe et al., 2009). Specific staphylococcal resistance to 
gentamicinis mediated by a bifuntional enzyme that acts as both acetyltranspherase and 
adenylyltranspherase. This enzyme is codified by the genes aac (6’)-Ie + aph (2") which are 
transported in transposon Tn4001 located in plasmids of pSK1 family, conjugative plasmids 
pSK23 and in the chromosome (Udo & Dashti, 2000). Genetic elements Tn4001 are 
disseminated in S. aureus and CNSs. There is little information about its occurrence in 
staphylococci of animal origin (Lange et al., 2003). 
3.4 Growth promoters 
Antibiotic use in sub therapeutic levels as growth promoters is still common in Brazilian 
animal production. Defenders of this model believe that antimicrobial abolishment will 
result in higher morbidity, with a consequent raise of antimicrobial therapeutic use and 
consequently higher mortality. Also they think that it will directly implicate the efficiency of 
productivity as animals without growth promoters have a higher food consumer to achieve 
the same weight gain.  
On the other hand, the European Economic Community established severe restrictions for 
products presenting antimicrobial residues defending the idea that this sub therapeutic use 
contributes to a positive selective pressure and to the spread of antimicrobial resistance 
genes between different pathogens. European Market defends that efficient animal handling 
is sufficient to control the infectious diseases and that avoid the probability of antimicrobial 
therapeutic failure. It is a highly controversial subject of extreme importance in a world 
concerned to the need of the improvement of food production. The experience of avoparcin 
use as growth promoter in some European countries and the consequent dissemination of a 
crossed-resistance to vancomicin in Enterococcus faecium and E. faecalis seems to be related to 
the adoption of these restrictive measures (Aarestrup et al., 1996) 
Since 2003, Brazil instituted a work group in order to analyze and evaluate the use of 
substances such as carbadox, olaquindox, bacitracin zinc, spiramycin, virginiamycin and 
tylosin phosphate as animal feed additives products. In 2005, it also included the evaluation 
of avilamycin, flavomycin, enramycin, monensin and maduramycin.  
The most efficient alternative to the antimicrobial indiscriminate use are probiotics. 
Probiotic acts in a significantly different mechanism from antimicrobials. They are thought 
to improve intestinal microbial balance through favoring the elimination of pathogenic 
bacteria and the proliferation of non pathogenic organisms. As a consequence it contributes 
to growth promotion without enhance antimicrobial resistance.  
4. Advances in the field of nucleic acid-based techniques for the 
identification/typing and detection of antibiotic resistant Staphylococcus 
species  
The importance of being able to identify staphylococci species routinely in clinical 
laboratories is increasing. However, the exact identification of CNS is not easy, because the 
biochemical traits of the species are very similar and many clinical isolates show 
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intermediate traits. Additionally, the use of commercial identification kits to identify 
staphylococci does not include all Staphylococcus species, and their reliability for certain 
species is not sufficient. Molecular methods of identification seem to be the key to fulfill 
these spaces, as gene specific markers are being recognized. In the same way, molecular 
techniques have been developed in order to improve the detection of antibiotic resistant 
bacterial strains. So, nucleic acid-based detection systems offer rapid and sensitive methods 
to detect the presence of resistance genes and play a critical role in the elucidation of 
resistance mechanisms. This topic will discuss the variety of nucleic-based techniques used 
for diagnostic applications and demonstrate that no universal technique exists which is 
optimal for detection of specific genes. The choice of a particular technique is also 
dependent on the information required or the targets under consideration, but some 
techniques are more favored than others. 
The advantages of genotypic detection of antibiotic resistance and bacterial characterization 
include: (i) The search for a defined resistance determinant; (ii) Independence upon 
phenotypic categories such as susceptibility, intermediate susceptibility and resistance for 
which breakpoints may vary between countries; (iii) Detection of low-level resistance which 
is difficult to detect using phenotypic methods; (iv) Reduction of the detection time through 
its performance directly with clinical specimens. This is particularly important for difficult-
to-culture organisms; (v) Reduction in detection time of slow growth of the organism; (vi) 
More precise and fast therapeutic predictions; (vii) Minor biohazard risk once it is not 
necessary to propagate by culture of a microorganism (Sundsfjord et al., 2004). 
On the other hand, the genotypic approach contains certain limitations and pitfalls: (i) It is 
based on screening for resistance determinants whereas antimicrobial therapy is preferably 
based on the detection of susceptibility; (ii) You can only screen for what you already know 
so it does not take into account new resistance mechanisms; (iii) There are silent genes and 
pseudogenes that may cause false-positive results. (iv) It may detect not clinically relevant 
resistance genotypes; (v) Mutations in primer binding sites can generate false-negative 
results; (vi) It presents low clinical sensitivity when performed directly on mixed microbial 
samples due to inhibition of nucleic acid amplification or a limited number of targets; (vii) 
Regulatory mutations that affect gene expression are not detected unless a quantitative 
measurement of the specific mRNA is targeted; (viii) Unlike for conventional culture-based 
susceptibility test methods, no standards exist for performing genetic testing methods 
(Sundsfjord et al., 2004). 
Nucleic acid-based technology can be divided into hybridization systems and amplification 
systems, although most amplification technologies are also partly based on hybridization 
technology. 
In hybridization, the DNA in a sample is rendered single stranded and allowed to combine 
with a single-stranded probe. Early hybridizations were performed with target DNA 
immobilized on a nitrocellulose membrane, but nowadays a variety of different solid 
supports are used. After binding of the target, the probe can hybridize. Probes can be 
labeled with a variety of reporters, including radioactive isotopes, antigenic substrates, 
enzymes or chemiluminescent compounds. Current modalities of hybridization DNA or 
RNA that have been used to detection of antimicrobial resistance in Staphylococcus spp. are 
Southern and Northern Blotting, FISH (Fluorescence In Situ Hybridization), microarray and 
Branched DNA (bDNA).  
www.intechopen.com
 
Antibiotic Resistance in Staphylococcus Species of Animal Origin 
 
283 
In Southern blotting, DNA becomes immobilized on a membrane and can be used as a 
substrate for hybridization analysis with labelled DNA or RNA probes that specifically 
target individual restriction fragments in the blotted DNA (Southern, 1975). The major 
difference between Southern and Northern blotting is that in the latter, RNA, rather than 
DNA, is immobilized in the membrane. The Southern blotting techniques was utilized to 
detect mecA gene in Staphylococcus aureus and to evaluate the efficiency of the techniques as 
PCR (Bignardi et al., 1996; Lan Mo & Qi-nan Wang, 1997). 
Fluorescence In Situ Hybridization (FISH) is a technique originally developed for clinical 
diagnosis (Levsky & Singer, 2003). This approach applies the principle of hybridization 
involving the penetration of a fluorescent labeled sequence-specific nucleic acid probe into 
fixed cells, followed by specific binding to the complementary sequences of the target 
nucleic acid. It allows rapid simultaneous detection of structurally intact target genes while 
they are with the associated organism or particle (Bottari et al., 2006). It involves direct 
detection of the DNA without amplification of the target sequence and can be especially 
useful to detect specific bacterial community and antibiotic resistance gene (Rahube & Yost, 
2010). A peptide nucleic acid fluorescence in situ hybridization (PNA FISH) (AdvanDx, 
Woburn, MA, USA) assay was development to rapidly detect Staphylococcus aureus (Forrest 
et al., 2006; Lawson et al., 2011). Peptide nucleic acid (PNA) molecules are pseudopeptides 
that obey Watson-Crick base-pairing rules for hybridization to complementary nucleic acid 
targets (RNA and DNA) (Nielsen et al., 1994). Due to their uncharged, neutral backbones, 
PNA probes exhibit favorable hybridization characteristics such as high specificities, strong 
affinities, and rapid kinetics, resulting in improved hybridization to highly structured 
targets such as rRNA. In addition, the relatively hydrophobic character of PNA compared to 
that of DNA oligonucleotides enables PNA probes to penetrate the hydrophobic cell wall of 
bacteria following mild fixation conditions that do not lead to disruption of cell morphology 
(Stefano & Hyldig-Nielsen, 1997). 
DNA microarrays are based on the principle of hybridization which allow the mass 
screening of sequences. The method is based upon gene-specific probes (oligonucleotides 
or PCR amplicons) deposited on a solid surface like glass or a silicon chip. The test DNA 
is extracted, labelled and hybridized to the array. Target-probe duplexes are detected with 
a reporter system. Probe-target hybridization is usually detected and quantified by 
detection of fluorophore-, silver-, or chemiluminescence-labeled targets to determine 
relative abundance of nucleic acid sequences in the target (Schena et al., 1995). Microarray 
technology enables detection of a large number of resistance genes in a single experiment 
and has the potential for significant automation in a microchip format. However, a cost-
effective and user-friendly format for application in antimicrobial susceptibility testing 
remains to be developed (Sundsfjord et al., 2004). There are many examples of the use of 
DNA microarray for detection of antibiotic resistance genes in staphylococcal (Cui et al., 
2005; Frye et al., 2006; Garneau et al., 2010; Monecke et al., 2007; Zhu et al., 2007a). 
Recently, a team of scientists at the University of Dublin, the Irish National MRSA 
Reference Laboratory and the University of Dresden and Alere Technologies in Germany 
identified a new MRSA strain using high throughput DNA microarray screening. The 
new strain is not detected as MRSA by routine conventional and real time DNA-based 
polymerase chain reaction (PCR) assays commonly used to screen patients for MRSA 
(Shore et al., 2011).  
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Branched DNA (bDNA) was developed by Chiron Corp. and uses multiple hybridization 
sites for enzyme-coupled probes (Nolte, 1998). Target-specific probes bound to a solid 
surface are allowed to capture target ssDNA. A second probe is allowed to hybridize with 
the target. This probe has a 5’ extension that does not hybridize with the target. This 
extension can hybridize with a bDNA probe. This probe has a bristle-like structure. At least 
15 bristles are attached to each probe, and as many as three alkaline phosphatase reporter 
molecules can bind to each bristle. A signal is generated by the addition of a 
chemiluminescent substrate. Branched DNA was used to detect mecA gene in Staphylococcus 
spp. culture and from blood (Kolbert et al., 1998; Zheng et al., 1999). 
The amplification systems include, but are not limited to, simple and multiplex PCR, PCR-
RFLP, PCR-single-strand conformation polymorphism (PCR-SSCP), DNA sequencing and 
real-time PCR. Amplification methods are more easily adapted in the laboratory compared 
to DNA probe assays and are the preferred methods for genetic detection of resistance 
determinants. An internal amplification control for both sample preparation and 
amplification is recommended to exclude false-negative results using consensus 16S rDNA 
primers or a more genus-or species-specific target; e.g. the nuc gene for Staphylococcus aureus 
(Brakstad et al., 1992; Hoorfar et al., 2004; Vannuffel et al., 1995). It is also critical that 
negative controls without template DNA and positive controls with defined targets be 
included to check for false-positive and false-negative results, respectively. 
The Polymerase Chain Reaction (PCR) was first described by Mullis et al. (1987), and its first 
diagnostic application was published by Saiki et al. (1988). The technique became broadly 
used after the introduction of a thermostable DNA polymerase from Thermus aquaticus (Taq 
DNA polymerase) (Saiki et al., 1988) and the development of automated oligonucleotide 
synthesis and thermocyclers. PCR involves cycles of heating the sample for denaturing, 
annealing of the primers, and elongation of the primers. It has been the most commonly 
used nucleic acid amplification technique in the detection of antimicrobial genes, including 
Staphylococcus aureus (Simeoni et al., 2008).  
Multiplex Polymerase Chain Reaction (Multiplex PCR) is a modification of PCR that have 
also been used to detection of antimicrobial genes in Staphylococcus aureus (Amghalia, et al., 
2009; Braoios et al., 2009; Zhang et al., 2005) which consists of multiple primer sets within a 
single PCR mixture to produce amplicons of varying sizes that are specific to different DNA 
sequences. By targeting multiple genes at once, additional information may be gained from 
a single test run that otherwise would require several times the reagents and more time to 
perform. 
The specificity of the amplicon can be confirmed by various methods such as restriction 
fragment length polymorphism (RFLP) analysis, single-strand conformational 
polymorphism (SSCP) analysis or DNA sequencing. 
Restriction Fragment Length Polymorphism, or RFLP is a technique that exploits variations 
in homologous DNA sequences. It refers to a difference between samples of homologous 
DNA molecules that come from different locations of restriction enzyme sites. In PCR-RFLP 
analysis, the PCR product is digested by restriction enzymes and the resulting restriction 
fragments are separated according to their lengths by gel electrophoresis. It has been used to 
detect groEL gene in order to differentiate CNS species (Santos et al., 2007). 
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In PCR-single-strand conformation polymorphism (PCR-SSCP), the PCR amplication 
product is denatured into two single-stranded molecules and subjected to nondenaturing 
polyacrylamide gel electrophoresis. Under nondenaturing conditions, the single-stranded 
DNA (ssDNA) molecule has a secondary structure that is determined by the nucleotide 
sequence, buffer conditions, and temperature. PCR-SSCP is capable of detecting more than 
90% of all single-nucleotide changes in a 200-nucleotide fragment (Hayashi, 1992). 
DNA sequencing is almost universally performed by dideoxysequencing (Sanger et al., 
1977) and is a well-known technique. Technological developments brought DNA 
sequencing within the capabilities of at least some diagnostic laboratories. The latest 
developments in nucleic acid sequence techniques, the pyrosequencing, have made the 
detection of mutational resistance easier by rapid DNA sequence analysis (Ronaghi et al., 
1998). This technique has been used in the detection of linezolid resistance in enterococci, 
and to identify point mutations in 23S rRNA genes of linezolid-resistance Staphylococcus 
aureus and Staphylococcus epidermis (Sinclair et al., 2003; Zhu et al., 2007b) as well as rapid 
bacterial identification (Ronaghi et al., 2002).  
The laborious post-PCR work and problems with carry-over contamination have been 
largely removed by the advent of real-time PCR, a powerful improvement on the basic PCR 
technique (Higuchi et al., 1993). The combination of fluorescent detection strategies with 
appropriate instrumentation enables a more accurate quantification of nucleic acids. This 
quantification is achieved by the measure ofthe increase in fluorescence during the 
exponential phase of PCR. The use of fluorescent agents and probes that only generate a 
fluorescence signal on binding to their target enables real-time amplification assays to be 
carried out in sealed tubes, eliminating the risk of carryover contamination. Different 
techniques are available to monitor real-time amplification. The amplification process can be 
monitored using nonspecific double-stranded deoxyribonucleic acid (DNA) binding dyes or 
specific fluorescent hybridization probes. 
Four different chemistries, SYBR® Green (Molecular Probes), TaqMan® (Applied 
Biosystems, Foster City, CA, USA), Molecular Beacons and Scorpions® are available for 
real-time PCR. 
Real-time PCR techniques have permitted the development of routine diagnostic 
applications for the microbiology laboratory (Espy et al., 2006; Mackay, 2004). Several 
reports have described the use of these techniques for detection of resistance determinants 
and surveillance of antimicrobial-resistant Staphylococcus spp. (Fang & Hedin, 2003; 
Huletsky et al., 2004; Palladino et al., 2003; Paule et al., 2005; Thomas et al., 2007; Volkmann 
et al., 2004). The ability to monitor the accumulating amplicon in real time is based on 
labelled primers, oligonucleotide probes and/or fluorescing amplicons producing a 
detectable quantitative signal related to the amount and specificity of the amplicon. Several 
improvements have been introduced. Reduced amplicon size, shorter cycling times and 
removal of separate post-PCR detection systems have allowed automation, reduced the 
detection time, and minimized the risk for carry-over contamination. Other significant 
technical developments include multiplex PCR assays using more than one primer set for 
simultaneous detection of several antimicrobial resistance genes (Depardieu et al., 2004; 
Martineau et al., 2000a; Sabet et al., 2006; Šeputienė et al., 2010; Suhaili et al., 2009). 
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4.1 Molecular Identification/Typing of Staphylococcus species 
Earlier studies on the taxonomy of Staphylococcus species based on DNA-DNA reassociation 
indicated that in the genus there were nine distinct species groups, represented by S. 
epidermidis, S. saprophyticus, S. simulans, S. intermedius, S. hyicus, S. sciuri, S. auricularis, S. 
aureus, and Staphylococcus caseolyticus (Kloos & George, 1991). Several molecular targets have 
been exploited for the molecular identification of Staphylococcus species, including the 16S 
rRNA gene (De Buyser et al., 1992), the tRNA gene intergenic spacer (Maes et al., 1997), the 
heat shock protein 60 (HSP60) gene (Kwok et al., 1999), and the femA gene (Vannuffel et al., 
1999). These targets, however, have been exploited through the technology of molecular 
probe hybridization, and therefore, they are useful only in laboratories that have the 
complete panel of probes and then only for identifying recognized Staphylococcus species. 
Further molecular targets that have been identified include the nuc gene, which occurs only 
in S. aureus (Brasktad et al., 1992), and a chromosomal DNA fragment specific for 
Staphylococcus epidermidis (Martineau et al., 1996). 
The rpoB, gene encoding the highly conserved β subunit of the bacterial RNA polymerase, 
has previously been demonstrated to be a suitable target on which to base the identification 
of enteric bacteria (Mollet et al.,1997), spirochetes (Renesto et al.,2000), bartonellas (Renesto 
et al.,2001), and rickettsias (Drancourt & Raoult, 1999). The gene has been shown to be more 
discriminative than the 16S ribosomal DNA (rDNA) gene, which has also been used for 
identifying staphylococal bacteria (Mollet et al., 1997). In contrast to the probe hybridization 
technique and the RFLP approach, sequencing enables any isolate to be characterized, 
including new species by their phylogenetic relationships.  
Other suitable targets for the molecular identification of Staphylococcus species that have 
been proposed include the femA gene, which was used in a multiplex PCR-reverse 
hybridization approach to identify 55 clinical isolates (Vannuffel et al.,1999). These, 
however, included only five Staphylococcus species, namely S. aureus, S. epidermidis, S. 
hominis, S. saprophyticus, and S. simulans. Finally, molecular identification methods for the 
identification of one or only a few Staphylococcus species have been reported for S. 
saprophyticus (Martineau et al., 2000b), S. aureus (Benito et al., 2000), and S. epidermidis 
(Wieser & Busse, 2000). Whole-genome DNA-DNA hybridization analysis (Svec et al., 2004) 
allows species identification, but the method is not suitable for routine use.  
Accurate and rapid typing of Staphylococcus aureus is crucial to the control of infectious 
organisms (Naffa et al., 2005), and many different pheno- and genotyping methods have 
been used to distinguish their strains. Typing methods should have high and relevant 
discriminatory power and typeability, good reproducibility, applicability to all organisms of 
interest, ease of use, portability and low cost (Struelens et al., 1996). The common 
phenotyping techniques used for discriminating between bacteria from a single species are 
serotype, biotype, bacteriophage typing, or antibiogram. Techniques DNA-based such as 
pulsed field gel electrophoresis (PFGE), amplified fragment length polymorphism (AFLP), 
and multilocus sequence typing (MLST) have been many used ( Melles et al., 2004; Murchan 
et al., 2003; Tenover et al., 1994). Other common techniques use the Polymerase Chain 
Reaction (PCR) targeted to specific sequences, for example ERIC-PCR; the resulting 
reactions yield fragments of different sizes, which can be used to discriminate between 
bacterial types. Sequencing an entire bacterial genome, and, using micro-array technologies, 
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comparing strains to a reference strain (comparative genomic hybridization) is now 
technically feasible; however, the cost and time required limits the applicability for most 
epidemiologic studies (Foxman et al., 2005).  
PFGE is the most commonly used method when studying local or short-term S. aureus 
epidemiology (Chung et al., 2000). PFGE involves embedding organisms in agarose, lysing 
the organisms in situ, and digesting the chromosomal DNA with restriction endonucleases 
that cleave infrequently (Finey, 1993; Goering & Winters, 1992). Slices of agarose containing 
the chromosomal DNA fragments are inserted into the wells of an agarose gel, and the 
restriction fragments are resolved into a pattern of discrete bands in the gel by an apparatus 
that switches the direction of current according to a predetermined pattern. The DNA 
restriction patterns of the isolates are then compared with one another to determine their 
relatedness. Multicentre studies using PFGE are now possible due to recent advances in the 
standardization of electrophoresis conditions (Chung et al., 2000; Oliveira et al., 2001) and 
the development of normalization and analysis software (Duck et al., 2003). Interpretative 
criteria for use in comparing complex PFGE patterns in outbreaks have been applied to non-
outbreak situations to track the national and international dissemination of S. aureus clones 
(Tenover et al., 1995). The use of PFGE typing with adjusted interpretation criteria for 
grouping patterns with < 7 bands difference has been shown to correspond to clonal 
assignments made by other methods (Denis et al., 2004). The main criticisms of this 
technique for S. aureus are that PFGE may, on occasion, be too discriminatory for other than 
local or short-term epidemiological analyses, the arbitrary nature of the interpretive criteria 
used and the requirement for occasional subjective analysis of complex band patterns 
(Murchan et al., 2004). 
Amplified fragment length polymorphism (AFLP) (Vos et al., 1995), a typing method, also 
documents the contribution of “accessory genetic elements” next to genome–core 
polymorphisms. AFLP scans for polymorphism in actual restriction sites and the 
nucleotides bordering these sites. As such it documents nucleotide sequence variation, 
insertions and deletions across entire genomes (Vos et al., 1995).  
Multilocus sequence typing (MLST) (Maiden et al., 1998) has had a large impact on the field 
of bacterial typing and it has been used as an investigatory tool in many studies of S. aureus 
evolution and epidemiology (Aires de Sousa et al., 2003, Coombs et al., 2004, Enright et al., 
2002; Mato et al., 2004). MLST characterizes bacterial isolates on the basis of sequence 
polymorphism within internal fragments of seven housekeeping genes, representing the 
stable “core” of the staphylococcal genome. Each gene fragment is translated into a distinct 
allele, and each isolate is classified as a sequence type (ST) by the combination of alleles of 
the seven housekeeping loci (Enright et al., 2002). MLST has a major advantage over PFGE 
as a reference method due to the unambiguous nature of DNA sequences which can be 
stored easily along with corresponding clinical information on each isolate in internet-linked 
databases. The S. aureus MLST website (www.mlst.net) currently contains information on > 
1500 isolates from humans and animals from 40 different countries and represents a useful 
global resource for the study of the epidemiology of this species and the surveillance of 
hyper-virulent and / or antibiotic resistant clones. 
The variety of molecular techniques used for diagnostic applications demonstrate that no 
universal technique exists which is optimal for detection of nucleic acids. The choice of a 
particular technique is also dependent on the information required or the targets under 
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consideration, but some techniques are more favored than others. Hence, the genetic 
approach based on today’s test principles cannot substitute for phenotypic methods in 
routine antimicrobial susceptibility testing. Novel resistance mechanisms will arise 
continuously or unknown pre-existing resistance genes will be mobilized from 
environmental reservoirs and spread under antimicrobial selection (Barlow et al., 2004). 
Thus, the role of traditional susceptibility testing will continue to be important. Rather the 
rationale for genetic assays is to complement conventional phenotypic analyses (Sundsfjord 
et al., 2004). Challenges that remain include the variety of point mutations or genes leading 
to resistance and the labor-intensive nature of current amplification methods. DNA chip 
technology combined with automated amplification techniques has the potential to meet 
these challenges. However, the development of DNA chips containing a broad range of 
resistance markers that are usable for many different species remains a formidable challenge 
and requires a broader knowledge of resistance markers than is currently available 
(Sundsfjord et al., 2004).  
5. The relevance of surveillance for the prediction of antibiotic resistance  
This topic discusses the relevance and limitations of surveillance initiatives in veterinary 
practice. Antibiotic resistance surveillance is based on the identification of new challenges, 
detection of new resistance mechanisms, monitoring the impact of new empiric antibiotic 
prescribing, identification of outbreaks of resistant organisms, detection of bacterial 
misidentification and promotion of the establishment of standards and guidelines for 
education and training for veterinaries, animal keepers, animal owners and the general 
public.  
Cats and dogs represent potential sources of spread of antimicrobial resistance due to the 
extensive use of antimicrobial agents in these animals and their close contact with humans. 
Modern society has contributed to radical changes in the relationship between companion 
animals and humans through the years, with a significant raise in cats and dogs population 
and to a closer contact with humans (Guardabassi et al., 2004).  
The introduction of a new drug, especially an antibiotic, has to be monitored in order to 
achieve its real benefit to the target audience. Recently, azithromycin was introduced to 
Brazilian pet market claiming to be an advantageous antimicrobial alternative to dogs and 
cats infections such as pyodermitis, external otitis, respiratory and urinary tract disturbs. 
Azithromycin have a remarkable application due to its superior pharmacokinetics 
properties and broad spectrum activity, including Gram-positive and negative bacteria 
species, intracellular pathogens and protozoan parasites. Pereira et al. (2009) evaluated the 
resistance to azithromycin of 225 clinical samples from different infectious sites of pet 
animals in order to establish the benefits of introducing this drug in veterinary therapy in 
Brazil since it has already been used for human therapy. Azithromycin resistance can be 
caused by several mechanisms, such as target modification mediated by a 23S rRNA 
methylase, presence of efflux pumps and drug inactivation (Lim et al., 2002). These 
resistance mechanisms were identified in a wide range of Gram-positive and negative 
bacteria, such as, Staphylococcus spp, Streptococcus spp, Enterococcus faecium, Corynebacterium 
spp, Pseudomonas aeruginosa, Escherichia coli and Bacteroides spp, all of them implicated in the 
etiology of household pets infections. Among them, Staphylococcus spp, a resident member 
of the normal cutaneous and mucosal microbiota of humans and animals, stands out as an 
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important pathogen involved in several animals infectious diseases due to its wide range of 
virulence factors and ability to overcome antimicrobial effects (Garber, 2001). Predominant 
staphylococci azithromycin resistance mechanisms are that mediated to erm(A) and erm(C) 
determinants of 23S rRNA methylase and mef genes that encode efflux pumps. The erm(A) 
genes are mostly spread in methicillin-resistant strains and are borne by transposons related 
to Tn554, whereas erm(C) genes are mostly responsible for macrolide resistance in 
methicillin-susceptible strains and are borne by plasmids (Lim et al., 2002). Most of the 
knowledge applied to define microbiologic use and dose of azithromycin was based on 
Staphylococcus aureus assays, because this specie acts as a classical pathogen of human 
infections, but the frame of etiology and antimicrobial susceptibility pattern change when 
animal pathogens are considered.  
Otherwise, gentamicin, even being the most utilized antimicrobial in bases for 
intramammary use, keeps its effectiveness against staphylococci isolated from mastitic milk. 
Those data support the idea of the importance of monitoring the impact of new/old empiric 
antibiotic prescribing  
6. Concluding remarks 
 Staphylococcus species distribution considers that different animal species have a different 
staphylococcal microbiota divided into coagulase-positive and coagulase-negative groups. 
In veterinary medicine, besides S. aureus, others coagulase-positive species are reported as 
important pathogens, such as Staphylococcus intermedius, the new specie S. 
pseudintermedius, S. delphini, S. schleiferi subsp. coagulans and S. aureus subsp. anaerobius. 
Several Coagulase-negative Staphylococci have been isolated from animal clinical 
specimens such as Staphylococcus epidermidis, Staphylococcus simulans, Staphylococcus 
xylosus, Staphylococcus chromogenes, Staphylococcus warneri, Staphylococcus haemolyticus, 
Staphylococcus sciuri, Staphylococcus saprophyticus, Staphylococcus hominis, Staphylococcus 
caprae, Staphylococcus cohnii subsp. cohnii, Staphylococcus cohnii subsp. urealyticus, 
Staphylococcus capitis subsp. capitis and Staphylococcus capitis subsp. urealyticus. 
 Staphylococcus aureus is considered the most pathogenic specie, especially due to its 
ability to produce a large range of virulence factors that enables it to colonize different 
tissues of a large range of animal species, such as coagulase, slime, protein A, 
hemolysins. Otherwise, like S. aureus, the S. intermedius strains isolated from animals 
have been reported to produce an array of virulence factors, including leukotoxin, 
enterotoxin, and hemolysins, together with elements essential for biofilm formation. 
 The epidemiological and clinical importance of Staphylococcal species is not only 
because of its distribution and pathogenicity but especially due to its ability to 
overcome antimicrobial effects. So there is a need for continued vigilance and 
systematic study to enlarge the understanding of its dynamic. Considering the spread 
of MRSA strains it is necessary to determine risk factors for animal infections, especially 
for household pets that live in strict contact to men, the relationship between animal 
and human carriage, and the genetic relationship of animal and human strains. 
 hVISA or VISA phenotype, mostly MRSA, have now been reported for many countries 
and it is considered to be related to the bacterial cell wall thickening, a passive 
resistance mechanism that reduces vancomycin access to its active site. Also MRSA 
strains that are also VRSA have been reported in the United States. VRSA phenotype is 
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due to acquisition from Enterococcus spp. of the vanA operon, carried by transposon 
Tn1546, resulting in high-level resistance. The emergence of enterococci vancomicin-
resistant strains has been related to the use of avoparcin as growth promoter in swine 
culture and it seemed to arise in staphylococci due to the transfer of glycopeptide- and 
macrolide-resistance genes by transconjugation among enterococci and from 
Enterococcus faecalis to S. aureus. 
 The large range of molecular techniques available for use demonstrates that no 
universal technique exists which is optimal for detection of nucleic acids. The choice of 
a particular technique is also dependent on the information required or the targets 
under consideration. Hence, the genetic approach based on today’s test principles 
cannot substitute for phenotypic methods in routine identification and antimicrobial 
susceptibility testing. 
 Antibiotic resistance surveillance is based on the identification of new challenges, 
detection of new resistance mechanisms, monitoring the impact of new empiric 
antibiotic prescribing, identification of outbreaks of resistant organisms, detection of 
bacterial misidentification and promotion of the establishment of standards and 
guidelines for education and training for veterinaries, animal keepers, animal owners 
and the general public.  
7. Future challenges 
Tenover (2008) in his article “Vancomicin-resistant Staphylococcus aureus: a Perfect but 
Geographically Limited Storm?” gives us a clue that antibitioc resistance issue is not so 
simple answer. Science is a creative activity that request exploration and gambling. We have 
to be open-minded to understand that some evolutionary steps are more successful than 
others and the pathways to resistance are not so predictable. As Tenover (2008) said: 
“Predicting which resistant strains will ultimately survive and disseminate is virtually 
impossible; predicting that at least some strains will disseminate broadly is a certainty.” The 
biggest challenge is keep researching in order to enhance our knowledge of the mechanisms 
beyond resistance, the evolutionary pathways of resistance among microorganisms, and 
selective pressure factors that contribute to the expression of underlying genes.  
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